« Back to Record
Citation APA

Naumann, R. W., Hollebecque, A., Meyer, T., Devlin, M. J., Oaknin, A., Kerger, J., López-Picazo, J. M., Machiels, J. P., Delord, J. P., Evans, T. R. J., Boni, V., Calvo, E., Topalian, S. S., Chen, T., Soumaoro, I., Li, B., Gu, J., Zwirtes, R., & Moore, K. K. (2019). Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(31), 2825-2834. doi:10.1200/JCO.19.00739


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/297143

Naumann, R. W., Hollebecque, A., Meyer, T., Devlin, M. J., Oaknin, A., Kerger, J., López-Picazo, J. M., Machiels, J. P., Delord, J. P., Evans, T. R. J., Boni, V., Calvo, E., Topalian, S. S., Chen, T., Soumaoro, I., Li, B., Gu, J., Zwirtes, R., & Moore, K. K. (2019). Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(31), 2825-2834. doi:10.1200/JCO.19.00739